Search Results

The Gauss Pixel App is intended to be used to aid current clinical practices in recording the number of surgical sponges and for visibility for assessment of sponge images.

Not Found

I am sorry I cannot fulfill your request to describe the acceptance criteria and study proving device efficacy based on the provided document. The document primarily consists of a 510(k) clearance letter from the FDA, an "Indications for Use" form, and general regulatory information. It does not contain the specific details about the acceptance criteria, study design, results, or data provenance you are asking for.

The information provided only states that the device is "substantially equivalent" to legally marketed predicate devices, which is the basis for 510(k) clearance. It does not include the detailed performance testing data that would be part of a full study report.

Ask a specific question about this device

The Gauss Pixel App is indicated for use to aid current practices in recording the number of surgical sponges and for visibility for assessment of sponge images.

The Gauss Pixel App is a software program used on an iPad tablet to capture images of sponges to assist surgical personnel in the management of surgical sponges after surgical The App allows surgical personnel to categorize sponges by sponge type and use. provides an automated ongoing count of total sponge images and sponge images by tag. It also provides a visual record of images for further evaluation. This program is not intended to replace existing sponge counting practices and sponges should be retained per the user's standard sponge management practice until the case is complete and sponge counting has been finalized.

Here's a summary of the acceptance criteria and study findings for the Gauss Pixel App, based on the provided document:

1. Acceptance Criteria and Reported Device Performance

2. Sample Size and Data Provenance

The document does not explicitly state the sample size used for a test set in the conventional sense of a clinical trial or independent validation. The performance claims are based on "software verification and validation testing." This typically involves internal testing by the developer to ensure the software meets its specified functional and non-functional requirements.

There is no information provided regarding the country of origin of data or whether it was retrospective or prospective. Given the nature of a 510(k) submission for a Class I device and the focus described (software verification and validation), it's highly probable that this involved internal testing rather than a large-scale clinical study with external patient data.

3. Number of Experts and Qualifications

The document does not specify the number of experts, their qualifications, or their role in establishing a "ground truth" for a test set. The validation described is primarily around the software's functional performance (e.g., counting, tagging, image display) rather than assessing clinical accuracy against expert opinion in a diagnostic context.

4. Adjudication Method

No adjudication method (e.g., 2+1, 3+1) is mentioned, as the described validation focuses on software functionality rather than interpreting findings against a 'ground truth' that would require expert consensus.

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

No MRMC comparative effectiveness study is mentioned. The device is described as an adjunctive tool to aid current practices, not as a replacement or independent diagnostic tool. The focus is on verifying its own functionality (counting, image display) rather than its impact on human reader performance. Therefore, an effect size of human readers improving with/without AI assistance is not reported.

6. Standalone Performance

Yes, a standalone (algorithm only without human-in-the-loop performance) assessment was done for the core functionalities of the application. The document states: "Results of performance testing confirmed that the application provided instructions for use, recorded images as indicated by the user, accurately tagged images as indicated by the user, accurately provided automated counting both in total and by type and allowed visual review and management (re-tagging, deletion) of all images as appropriate." This describes the independent functional performance of the software.

7. Type of Ground Truth Used

For the described performance testing, the "ground truth" appears to be the expected functional behavior of the software as defined by its specifications and design. For example:

• For "accurately provided automated counting," the ground truth would be the actual number of images taken and the actual type assigned by a user, against which the software's automated count is compared.
• For "accurately tagged images," the ground truth is the tag the user intended to apply, against which the software's recorded tag is compared.

It does not refer to medical ground truth like pathology, outcomes data, or expert consensus on a diagnostic interpretation.

8. Sample Size for the Training Set

The document does not specify a sample size for a training set. This is consistent with the nature of the device as a functional tool for managing sponges, not a machine learning model that requires a large training dataset to develop its core functionality (like image recognition for diagnostic purposes). The "training" described implicitly refers to the software development and testing cycles designed to ensure correct functionality.

9. How Ground Truth for the Training Set Was Established

Given the information provided, the concept of a "ground truth for the training set" as it pertains to typical AI/ML development (e.g., labeled data for model training) is not applicable here. The ground truth for the development and verification of the software's core functions (counting, tagging) would have been established by the software's design specifications and the expected, correct outputs for given inputs during testing. This is standard software engineering practice rather than a data-driven ground truth for a machine learning algorithm.

Ask a specific question about this device

The ORLocate™ system is indicated for use in recording and counting the number of RFID-tagged surgical sponges, laparotomy sponges, towels and other tagged items used during surgical procedures in which counting is required. In addition, the product is indicated for providing a non-invasive means of detecting retained RFID-tagged surgical sponges, towels and other tagged items within a surgical site, as an adjunctive detection method to current surgical counting systems and methods.

Haldor ORLocate™ system is an RFID system providing a solution that enables the enumeration of sponges and surgical manual instruments, utilizing passive tags for keeping track of the items during surgery and to identify counting problems. In addition, the system provides a non-invasive means of locating retained surgical items within a surgical site. The submission consists of the ORLocate™ system which includes: cart and antennas. Additionaly the submission includes accessories which are: associated single use surgical sponges, gauzes, pads and surgical towels each fitted with a uniquely coded RFID tag and uniquely coded RFID tag used for surgical instruments. The RF frequency the system uses is 13.56 MHz according to ISO 15693. The system supplies also a semi-automatic application to help in counting untagged items, the count information is first entered manually and the calculations are automatic.

The ORLocate™ System is an RFID-based system for counting and detecting surgical items. The provided document, a 510(k) Summary, details the device's technical characteristics, intended use, and non-clinical performance data to demonstrate substantial equivalence to predicate devices.

1. Table of Acceptance Criteria and Reported Device Performance

The document does not explicitly state "acceptance criteria" with numerical thresholds for performance. However, based on the non-clinical performance data section, the criteria can be inferred from the tests performed and the conclusion that the device functions as intended and is as safe and effective as predicate devices.

2. Sample Size Used for the Test Set and Data Provenance

The document states "Non-clinical testing included demonstrating performance of system and tagged items in laboratory tests." However, it does not specify the sample sizes used for any of the tests (e.g., how many sponges were tested for counting accuracy, how many instruments for tag pull test).

The data provenance is described as "laboratory tests," implying controlled settings rather than real-world clinical data. The document does not mention the country of origin of the data explicitly, but the 510(k) owner is based in Israel, suggesting the testing likely occurred there or in collaboration with international labs. The study is retrospective in the sense that the testing was performed and then reported for the 510(k submission.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

The document does not provide information on the number of experts used or their qualifications for establishing ground truth for the test set. Given the nature of the non-clinical tests (e.g., biocompatibility, tag attachment, software counting accuracy), ground truth would likely be established through objective measurements and validated procedures rather than solely expert consensus.

4. Adjudication Method for the Test Set

The document does not describe any adjudication method for the test set. Given that the non-clinical tests are largely objective performance evaluations (e.g., measuring count accuracy, pull force, EMC compliance), an adjudication method in the context of expert review is unlikely to be relevant.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was Done

No, a Multi-Reader Multi-Case (MRMC) comparative effectiveness study was not done. The document focuses on non-clinical performance data to establish substantial equivalence, not on human reader performance with or without AI assistance.

6. If a Standalone (i.e. algorithm only without human-in-the-loop performance) was Done

Yes, the non-clinical tests described are essentially standalone performance evaluations of the algorithm and device. The "counting accuracy test" and validation that the "software functioned as intended under simulated use, properly counting sponges in body fluids" demonstrate the algorithm's performance without direct human-in-the-loop assistance for the core counting mechanism. The system is designed to perform automatic counts and provide alerts if items are missing, which is a standalone algorithmic function.

7. The Type of Ground Truth Used

The ground truth used for the non-clinical tests would have been established through:

• Objective measurement/validation: For counting accuracy, the actual number of sponges present would be the ground truth. For tag pull tests, the measured force would be compared against a standard.
• Established standards: Compliance tests like IEC 60601-1-2:2007 and IEC 60601-1:1988 + A1:1991 + A2:1995 refer to external ground truths established by international standards bodies.
• Simulated environment: For the software, simulated body fluids were used to test performance, implying a controlled and known environment against which the device's output was compared.

8. The Sample Size for the Training Set

The document does not mention a training set sample size. The system described is an RFID detection and counting system, which typically relies on pre-programmed logic for tag identification and counting, rather than a machine learning model that requires a "training set" in the conventional sense. If there are any adaptive or learning components, they are not detailed in this summary.

9. How the Ground Truth for the Training Set Was Established

Since a training set is not mentioned for machine learning purposes, the method for establishing its ground truth is not applicable/not provided. The system's operational parameters (e.g., RFID tag protocols, counting logic) would be established through engineering design and validation, not model training.

Ask a specific question about this device

The ClearCount Medical Solutions SmartWand-DTX™ System is indicated for use in counting and displaying the number of RFID-tagged surgical sponges, laparatomy sponge, and towels detected by the device and providing a noninvasive means of locating retained RFID-tagged surgical sponges, towels, and other tagged items within a surgical site.

The SmartWand-DTX™ System is based on radio frequency identification (RFID) tags. The RFID tags are provided to manufacturers of surgical disposables for inclusion into their surgical sponges, laparotomy pads and surgical towels. The disposable manufacturer permanently attaches the RFID tags to the gauze or fabric of the disposables. The tags are then programmed to contain information about the type and number of disposables in the package. This allows the sponges, pads, and towels to be individually recognized by an RFID reader. The RFID tag function is the same as that for the SmartSponge Plus System.

The SmartWand-DTX is a device comprised of a handheld scanning antenna that is attached to an electronics box that contains an RFID reader and supporting electronics. Integrated RFID technology allows the capture of the information coded on the unique RFID tags in the sponges, pads and towels. When the tagged sponges, pads, and towels are detected by the scanning wand, the device displays the type and number of each type of item that is detected. The system recognizes RFID-tagged items that may be inside the surgical site.

Here's an analysis of the acceptance criteria and study information for the ClearCount Medical Solutions SmartWand-DTX System, based on the provided text:

Important Note: The provided document is a 510(k) summary, which focuses on demonstrating substantial equivalence to predicate devices rather than providing a detailed clinical study report with specific performance metrics and statistical analysis. Therefore, much of the requested information (like specific sample sizes for test/training sets, detailed expert qualifications, MRMC data, and quantitative ground truth establishment) is not explicitly stated in this type of regulatory submission. The answers below are derived directly from the available text.

1. Table of Acceptance Criteria and Reported Device Performance

Study Information:

2. Sample Size Used for the Test Set and Data Provenance

• Sample Size: Not explicitly stated. The text mentions "simulated use" and "verification and validation testing," but no specific number of cases or items tested is provided.
• Data Provenance: The testing was "Non-Clinical," conducted in a "laboratory setting." There is no mention of human subject data, retrospective, or prospective studies in a clinical environment.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

• Not explicitly stated. Given the non-clinical, laboratory setting, ground truth would likely refer to the known presence and location of RFID tags placed by the testing personnel rather than expert clinical consensus.

4. Adjudication Method for the Test Set

• Not applicable/Not stated. Since the testing was non-clinical and involved detecting pre-placed tags, a formal adjudication method by experts (like 2+1 or 3+1) is not relevant in this context. The "ground truth" would be the known, objective presence/absence/location of the tags.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, If So, What Was the Effect Size of How Much Human Readers Improve with AI vs. Without AI Assistance

• No, a Multi-Reader Multi-Case (MRMC) comparative effectiveness study was not done. This device is a standalone detection system, not an AI-assisted diagnostic tool for human readers. It's intended to replace manual counting and provide localization, not enhance human interpretation of images. Consequently, there's no mention of "human readers" or "AI assistance."

6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done

• Yes, a standalone performance assessment was conducted. The device (SmartWand-DTX System) is described as "algorithm only without human-in-the-loop performance" in terms of its core detection and counting function. It directly detects RFID tags and displays information. The testing involved the device's ability to "properly locating all tags" in simulated use.

7. The Type of Ground Truth Used

• The ground truth in the non-clinical testing was based on the known, objective presence and location of RFID-tagged items placed by the testing personnel in a simulated environment. It was not expert consensus, pathology, or outcomes data, as those are relevant to clinical diagnostic devices.

8. The Sample Size for the Training Set

• Not specified. The document primarily discusses verification and validation testing, not the training of a machine learning algorithm. While the device contains a "proprietary software operating on a microcontroller unit," specific "training set" data for an AI model is not detailed. The system is based on RFID technology and reading unique identifying numbers, which implies a more deterministic operating principle rather than a continuously learning AI model that requires a discrete training set.

9. How the Ground Truth for the Training Set Was Established

• Not applicable/Not specified as a distinct "training set" in the context of an AI algorithm. The device relies on reading pre-programmed RFID tags. If there was any internal calibration or refinement, it's not described in terms of a formal training set.

Ask a specific question about this device

The ClearCount Medical Solutions SmartSponge™ PLUS System is indicated for use in counting and recording the number of RFID-tagged surgical sponges, laparatomy sponges and towels used during surgical procedures, as well as for providing a non-invasive means of locating retained RFID-tagged surgical sponges, towels, and other tagged items within a surgical site.

The SmartSponge™ PLUS System includes surgical sponges, laparatomy pads and surgical towels, each of which contains a unique radio frequency identification (RFID) tag permanently attached to the gauze or fabric. The tags allow the sponges and towels to be individually recognized by an RFID reader.

The SmartBucket is a specially designed cart containing a microcontroller unit with specialized software designed for mobile data collection. Integrated RFID technology allows capture of the information coded on the unique RFID tag on the sponges, pads and towels. The microcontroller unit counts the initial number of sponges introduced into a surgical case, and using the custom software program, reports the total sponges discarded at the end of the procedure, and compares that number to the original. By providing a count of the items entered into surgery, and a count of those discarded and removed permanently from the surgical field, personnel can be alerted to sponges that may still remain in the surgical field prior to closing the patient.

A Detection Wand is an additional antenna that is tethered by a cable to the SmartBucket. It is powered and controlled by the SmartBucket. The antenna functions as an additional RFID antenna to the system, functioning in an identical manner to the internal SmartBucket antennas. By using a keypad the user may select activate the Detection Wand antenna. When in Detection Wand mode, the system uses the Wand antenna to recognize RFID-tagged items that may be inside the surgical site.

A Detection Mat is a disposable or reusable element with multiple RFID tags embedded inside, along with several passive printed circuit traces. Like the RFID-tagged sponges, the Detection Mat tags contain unique identifying numbers and are distinguishable by the system software. The Detection Mat is placed on the operating room table before the patient is brought into the room and is covered by the standard sheets or drapes used in surgery, thus not making contact with the patient. The RFID tags in the Matt provide feedback to the user that the Detection Wand is being held close enough to the patient to ensure proper reading. The tags in the Detection Mat also ensure that the Detection Wand scan has covered the appropriate areas of the patient. The passive circuit traces help to enhance the readability of the RFID tags in the Detection Mat.

Here's an analysis of the provided text regarding the ClearCount Medical SmartSponge™ PLUS System, focusing on acceptance criteria and supporting study details:

1. Table of Acceptance Criteria and Reported Device Performance

2. Sample Size Used for the Test Set and Data Provenance

The document mentions "simulated use in patient models that represented worst case biological situations." However, no specific sample size (number of simulated cases, number of sponges, or number of tests) for the test set is provided.

The data provenance is from non-clinical testing, using simulated patient models. The document does not specify the country of origin, but given the FDA submission, it's presumably conducted under U.S. regulatory standards or by a manufacturer seeking to market in the U.S. It explicitly states "Non-Clinical testing," confirming it's not a prospective or retrospective study involving actual patients.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

This information is not provided in the document. The "ground truth" for the simulated use in patient models would likely have been established by the study designers or engineers setting up the scenarios of "worst case biological situations" and knowing the expected location and quantity of tagged items. There is no mention of independent experts establishing this ground truth.

4. Adjudication Method for the Test Set

This information is not provided. Without details on who assessed the device's performance in the "simulated use," an adjudication method cannot be determined.

5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

No, an MRMC comparative effectiveness study was not done. The device's primary function is to automate sponge counting and aid in detection, not to assist human readers in interpreting medical images in the traditional sense of an MRMC study. The "Detection Wand" is a tool for locating tagged items, not for improving human interpretation of visual data.

6. If a Standalone (i.e. algorithm only without human-in-the-loop performance) was done

Yes, a form of standalone performance was implicitly evaluated for the detection component. The statement "The validated software functioned as intended under simulated use, properly locating all tags" suggests the algorithm's ability to locate tags independently within the simulated environment. While a human operates the Detection Wand, the core detection by the RFID system and its interpretation by the software is a standalone algorithm function. The counting function is also purely algorithmic.

7. The Type of Ground Truth Used

The ground truth used was based on pre-defined scenarios within simulated patient models where the exact quantity and location of RFID-tagged items would be known to the experimenters. This is an engineered or experimental ground truth, not derived from expert consensus, pathology, or outcomes data from real patients.

8. The Sample Size for the Training Set

The document does not provide information on the sample size for a training set. The device appears to rely on established RFID technology and programmed logic, rather than a machine learning model that would typically require a training set in the conventional sense. If there was any "training" (e.g., for system calibration), its details are not mentioned.

9. How the Ground Truth for the Training Set was Established

Since no training set is mentioned or implied for a typical machine learning model, this information is not applicable / not provided. The functionality seems to be based on direct sensing and programming, not a learned model from data.

Ask a specific question about this device

The ClearCount Medical Solutions SmartSponge™ System is indicated for use in counting and recording the number of RFID-tagged surgical sponges, laparatomy sponges and towels used during surgical procedures.

The SmartSponge™ System includes surgical sponges, laparatomy pads and surgical towels, each unit of which contains a unique radio frequency identification (RFID) tag permanently attached to the gauze or fabric. The tags allow the sponges and towels to be individually recognized by an RFID reader.

The SmartBucket is a specially designed cart containing a microcontroller unit with specialized software designed for mobile data collection. Integrated RFID technology allows capture of the information coded on the unique RFID tag on the sponges, pads and towels. The microcontroller unit counts the initial number of sponges introduced into a surgical case, and using the custom software program, reports the total sponges discarded at the end of the procedure, and compares that number to the original. By providing a count of the items entered into surgery, and a count of those discarded and removed permanently from the surgical field, personnel can be alerted to sponges that may still remain in the surgical field prior to closing the patient.

The ClearCount Medical Solutions SmartSponge™ System is designed to count and record RFID-tagged surgical sponges, laparotomy sponges, and surgical towels during surgical procedures. The provided text outlines non-clinical performance data and results.

Here's a breakdown of the requested information:

1. Table of acceptance criteria and reported device performance:

2. Sample size used for the test set and the data provenance:

The document states "simulated finished product testing of the total system" and "properly counting sponges in simulated body fluids." However, it does not specify the sample size for this test set nor the data provenance (e.g., country of origin, retrospective or prospective).

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

The document does not specify the number of experts used or their qualifications for establishing ground truth for the test set. The ground truth for counting accuracy was established through "simulated use, properly counting sponges in simulated body fluids," implying a controlled experimental setup rather than expert interpretation of medical images or conditions.

4. Adjudication method for the test set:

The document does not specify an adjudication method (such as 2+1 or 3+1) for the test set. Given the nature of the device (counting sponges), the ground truth for counting accuracy would likely be directly observable and verifiable rather than requiring expert adjudication.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, and the effect size:

No, a multi-reader multi-case (MRMC) comparative effectiveness study was not explicitly mentioned or described in the provided text. The document compares the device's accuracy and effectiveness to "hand counting sponges" but does not provide specific effect sizes for human readers with or without AI assistance in an MRMC study.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done:

Yes, a standalone performance study was done implicitly. The "software validation of the SmartBucket scanning device" and "simulated finished product testing of the total system" describe the device's ability to "properly count sponges" without human intervention for the counting process itself. The system is designed to provide a count that personnel then use to determine if sponges remain.

7. The type of ground truth used:

The ground truth used for the counting accuracy of the SmartSponge System was directly observable and verifiable counts in simulated use conditions, specifically "properly counting sponges in simulated body fluids." This is an objective measurement of the device's functionality rather than expert consensus, pathology, or outcomes data.

8. The sample size for the training set:

The document does not specify the sample size for any training set. Given the context of a 2007 510(k) submission for a device using RFID for counting, it's possible that traditional "training sets" in the modern machine learning sense were not explicitly defined or reported in the same way. The software validation suggests a designed and tested algorithm rather than a continuously learning AI model.

9. How the ground truth for the training set was established:

The document does not describe how ground truth for a training set (if one was formally used) was established. The software validation likely involved testing against known, correct counts of sponges in controlled environments.

Ask a specific question about this device

The Medline Surgical Sponge Scanning System is intended to be used to augment current sponge counting practice by providing a means to electronically detect potentially retained springes,

Not Found

The provided text is a 510(k) clearance letter from the FDA for the Medline Surgical Sponge Scanning System. It does not contain information about acceptance criteria, study design, or device performance metrics.

Therefore, I cannot answer your request based on the provided input. The document mainly states that the device is substantially equivalent to legally marketed predicate devices and is cleared for marketing.

Ask a specific question about this device

The RF Surgical Systems Inc. Detection System is intended to provide a non-invasive means of locating retained surgical sponges, gauze and other tagged items within a surgical site. It is to be employed as an adjunctive detection method to current surgical sponge and gauze counting systems and methods

The RF Surgical Systems Inc. Detection System consists of:

1. The Power/Control Console contains the electronics that power and control the detector/scanner. The console also includes the user interface for system operation and communication of the system status, operation and alarms to the user.
2. The Transponder/Tag is a single use electrically passive device that is designed to radiate a magnetic signature when stimulated by magnetic impulses from the detector/scanner. The tag does not store or communicate any information or unique code and is to be mechanically attached to guaze sponges at the manufacturing site and processed as part of the item
3. The Detection Wand is a transceiver type antenna designed to stimulate the transponder tag assembly with magnetic impulses and then detect the resultant magnetic signature from the tag. The Power/Control Console provides the power and control to the detection scanner. The detection scanner is intended and designed to be a single-use disposable device and will be supplied in a sterile condition as it will enter the surgical field.

Here's an analysis of the acceptance criteria and study information for the RF Surgical Systems Inc. Detection System, based on the provided document:

1. Table of Acceptance Criteria and Reported Device Performance

The provided document does not explicitly present a table of quantitative acceptance criteria with corresponding performance metrics in the format typically seen for algorithm performance (e.g., sensitivity, specificity, AUC). Instead, it describes functional requirements and then states that the device "performed as intended."

Based on the "Technological Characteristics" and "Non-Clinical Performance Data" sections, here's an interpretation of the implied acceptance criteria and the reported performance:

2. Sample Size and Data Provenance for the Test Set

• Sample Size: The document does not provide a specific numerical sample size for the test set used in non-clinical testing. It mentions "simulated use in patient models" and "Animal studies using large swine species."
• Data Provenance:
  • Simulated Use in Patient Models: These are likely laboratory or in-house simulations.
  • Animal Studies: "large swine species" were used. The country of origin for these animal studies is not specified, but it's implied to be part of the manufacturer's testing process for FDA submission.
• Retrospective or Prospective: Both "simulated use" and "animal studies" would typically be considered prospective in nature, as they were conducted specifically to test the device.

3. Number of Experts and Qualifications for Ground Truth

The document does not explicitly state that experts were used to establish ground truth in the traditional sense of consensus reading for image analysis. Rather, the ground truth for "locating all tags" in the simulated and animal studies would have been the known physical presence and location of the tagged sponges or items.

4. Adjudication Method for the Test Set

Given the nature of the device (detection of physical tags) and the described testing (simulations, animal studies where tags are physically present), an adjudication method like 2+1 or 3+1 for expert consensus is not applicable. The "ground truth" is directly observable.

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

No. The document describes a standalone performance study of the device itself (detecting tags), not a comparative effectiveness study involving human readers with and without AI assistance (which is not an AI device in the typical sense, but rather a detection system). Therefore, no effect size of human reader improvement is reported.

6. Standalone (Algorithm Only) Performance

Yes, a standalone performance assessment was conducted. The "Non-Clinical Performance Data" section describes testing where the "RF Surgical Detection System performed as intended" and "the validated software functioned as intended under simulated use, properly locating all tags." This indicates an evaluation of the device's ability to detect tags independently.

7. Type of Ground Truth Used

The ground truth used was:

• Known physical presence and location of tagged items: In simulated patient models and animal studies, the researchers would have known precisely where the tagged sponges were placed.
• Biocompatibility data: For biocompatibility, the ground truth would be established through standard biological testing methods and comparison to known safe materials (predicates), likely through laboratory analysis rather than expert consensus on images.

8. Sample Size for the Training Set

The document does not provide information about a "training set" for the device. This device is described as an RF detection system using transponder tags and a detection wand, not an AI/machine learning system that typically requires a large training dataset. The "software" mentioned likely refers to control and processing logic rather than a trainable AI algorithm.

9. How Ground Truth for the Training Set Was Established

As no training set is indicated, this question is not applicable based on the provided text. The device's operation is based on physical principles of radio frequency detection, not on learning from data.

Ask a specific question about this device

The SurgiCount Medical Safety-Sponge System™ is indicated for use in counting and recording the number of thermally labeled surgical sponges, laparotomy sponges and towels used during surgical procedure.

The Safety Sponges include surgical sponges, laparatomy pads and surgical towels, each unit of which contains a unique identification label permanently fused to the gauze or fabric. The labels allow the sponges and towels to be individually recognized by a commercially available sight laser imager.

The Safety Sponge Counter is a commercially available mobile computer with specialized software designed for mobile data collection. Integrated imaging technology allows capture of the information coded in the unique identification label on the sponges, pads and towels. The computer counts the initial number of sponges opened, and using the custom software program, reports the total sponges used at the end of the procedure or on demand, and compares that number to the original. Individual sponges may be identified as entered into the surgical field but not discarded, so that the surgical field can be explored before surgically closing the patient.

Here's an analysis of the provided text regarding the SurgiCount Medical Safety-Sponge System's acceptance criteria and study:

1. Table of Acceptance Criteria and Reported Device Performance

The document does not explicitly state quantitative acceptance criteria (e.g., "accuracy must be >99%"). Instead, it focuses on qualitative substantial equivalence and functional performance.

2. Sample Size Used for the Test Set and Data Provenance

• Test Set Sample Size: Not explicitly stated. The clinical study involved a "surgical setting" but the number of procedures, sponges, or specific data points is not quantified.
• Data Provenance: Clinical data was prospective ("tested clinically under non-significant risk IRB approvals in a surgical setting"). The country of origin is not specified, but given the 510(k) submission to the FDA, it is highly likely to be the United States.

3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications

This information is not provided in the document. The document mentions "operating personnel's assessment," but it doesn't specify if these personnel established ground truth for sponge counts or if their assessment was for user experience.

4. Adjudication Method for the Test Set

This information is not provided in the document.

5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

• No Multi-Reader, Multi-Case (MRMC) study was explicitly mentioned. The study compared the device (AI) to traditional hand counting and assessed accuracy and time efficacy. It did not evaluate human readers with and without AI assistance in the traditional MRMC sense.
• Effect Size: Not applicable, as an MRMC study of human readers with/without AI assistance was not performed. The text does state the system makes its use "more effective than hand counting sponges" and provides "improved accuracy," but no specific quantitative effect size is given for human performance enhancement.

6. Standalone (i.e., algorithm only without human-in-the-loop performance) Study

• Yes, a standalone performance study was done. The core of the product is a "mobile computer with specialized software" that performs the counting. The "software validation of the hand-held scanning device" and "simulated finished product testing of the total system" where the software "properly counting sponges in simulated body fluids" directly demonstrate algorithm-only performance. The clinical study also validates the system's ability to "accurately counted surgical sponges into and out of the field, on both clean and soiled sponges," implying standalone algorithm accuracy.

7. Type of Ground Truth Used

Based on the description, the ground truth was likely established through manual, independent counting of sponges for comparison with the device's count. The description implies that the study aimed to verify the accuracy of the device's count against a known correct count (the actual number of sponges).

8. Sample Size for the Training Set

This information is not provided in the document. The document describes the system as using "commercially available" components and software "similar to the predicate software" for inventory control, suggesting it may not have required extensive de novo training data for a complex machine learning model in the modern sense. It's more likely a rule-based or OCR-like system.

9. How the Ground Truth for the Training Set Was Established

This information is not provided in the document, and it's unclear if a distinct "training set" with ground truth, as understood in modern AI development, was even used. Given the technology described (reading unique ID labels with a laser imager), the system might be more of a deterministic counting system rather than an AI model requiring a large, annotated training set. Its functionality relies on reliable label reading and matching, not "learning" from diverse input data to classify or detect.

Ask a specific question about this device

Markwell Gauze Sponges are nonsterile and for external use. It is supplied in bulk package (100/200pcs per package). To use it, simply apply the gauze pad to the area and change it when wet, or more often if needed.

Markwell Gauze Sponges may be repacked and sterilized by domestic manufacturer. If so, users have to follow the manufacturer's instructions to use it.

Markwell Gauze Sponges are nonsterile and for external use. It is supplied in bulk package (100/200pcs per package).

The provided text is a 510(k) premarket notification letter from the FDA regarding the Markwell Gauze Sponge. This document does not contain any information regarding acceptance criteria or a study that proves the device meets specific performance criteria.

The letter is a regulatory document stating that the FDA has determined the device is substantially equivalent to legally marketed predicate devices and can therefore be marketed. It discusses general controls, classification, and responsibilities under the Federal Food, Drug, and Cosmetic Act.

Specifically, the document lacks the following information which would be necessary to answer the prompt:

1. A table of acceptance criteria and the reported device performance: This type of data is not present in the regulatory notification.
2. Sample size, data provenance, number of experts, qualifications, adjudication method related to a performance study: No such study is described.
3. MRMC comparative effectiveness study or standalone performance study: These types of studies are not mentioned.
4. Type of ground truth used or how it was established: Not applicable, as no performance study is detailed.
5. Sample size for the training set: Not applicable, as no algorithm or AI is mentioned.

The "Indications for Use" section simply describes how the gauze sponges are to be used (nonsterile, external use, direct application, repacking and sterilization by domestic manufacturer if applicable). This is not a performance specification or acceptance criteria based on a study.

Ask a specific question about this device